This study attempts to improve TRUS-guided prostate biopsy by utilizing assistance from a novel robotic TRUS manipulator (TRUS-Robot) developed by our team. The hypothesis of the study is that clinically significant prostate cancer detection rate from the SB cores (at SB or TB+SB) can be improved above that of current devices. The objective of the study is to gain early evidence on the effectiveness of prostate biopsy assisted by the TRUS-Robot vs. a current TB device in a randomized clinical trial.
Age
45–75
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Scheduled for an initial diagnostic biopsy
Elevated serum PSA (prostate specific antigen\> 4 ng/ml) and/or abnormal digital rectal exam
